213 related articles for article (PubMed ID: 26089647)
1. Protective effect of galangin in Concanavalin A-induced hepatitis in mice.
Luo Q; Zhu L; Ding J; Zhuang X; Xu L; Chen F
Drug Des Devel Ther; 2015; 9():2983-92. PubMed ID: 26089647
[TBL] [Abstract][Full Text] [Related]
2. Hepatoprotective Effect of Wedelolactone against Concanavalin A-Induced Liver Injury in Mice.
Luo Q; Ding J; Zhu L; Chen F; Xu L
Am J Chin Med; 2018; 46(4):819-833. PubMed ID: 29737211
[TBL] [Abstract][Full Text] [Related]
3. Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-kappaB activation.
Feng D; Mei Y; Wang Y; Zhang B; Wang C; Xu L
Immunol Lett; 2008 Dec; 121(2):127-33. PubMed ID: 18992279
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury.
Wang Y; Mei Y; Feng D; Xu L
Clin Exp Immunol; 2006 Sep; 145(3):485-92. PubMed ID: 16907918
[TBL] [Abstract][Full Text] [Related]
5. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
Xu X; Hu Y; Zhai X; Lin M; Chen Z; Tian X; Zhang F; Gao D; Ma X; Lv L; Yao J
Toxicol Appl Pharmacol; 2013 Nov; 273(1):68-76. PubMed ID: 23993977
[TBL] [Abstract][Full Text] [Related]
6. Sodium tanshinone IIA sulfonate protects mice from ConA-induced hepatitis via inhibiting NF-kappaB and IFN-gamma/STAT1 pathways.
Xu Y; Feng D; Wang Y; Lin S; Xu L
J Clin Immunol; 2008 Sep; 28(5):512-9. PubMed ID: 18498044
[TBL] [Abstract][Full Text] [Related]
7. Aqueous extract of Yin-Chen-Hao decoction, a traditional Chinese prescription, exerts protective effects on concanavalin A-induced hepatitis in mice through inhibition of NF-kappaB.
Cai H; Song YH; Xia WJ; Jin MW
J Pharm Pharmacol; 2006 May; 58(5):677-84. PubMed ID: 16640837
[TBL] [Abstract][Full Text] [Related]
8. Preventive effects of (5R)-5-hydroxytriptolide on concanavalin A-induced hepatitis.
Zhou R; Tang W; Ren YX; He PL; Yang YF; Li YC; Zuo JP
Eur J Pharmacol; 2006 May; 537(1-3):181-9. PubMed ID: 16603150
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1.
Jaruga B; Hong F; Kim WH; Gao B
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1044-52. PubMed ID: 15246962
[TBL] [Abstract][Full Text] [Related]
10. Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: alcohol disregulation of NF-kappaB and STAT3 signaling pathways.
Jaruga B; Hong F; Kim WH; Sun R; Fan S; Gao B
Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G471-9. PubMed ID: 15064234
[TBL] [Abstract][Full Text] [Related]
11. Galangin Prevents Acute Hepatorenal Toxicity in Novel Propacetamol-Induced Acetaminophen-Overdosed Mice.
Tsai MS; Chien CC; Lin TH; Liu CC; Liu RH; Su HL; Chiu YT; Wang SH
J Med Food; 2015 Nov; 18(11):1187-97. PubMed ID: 26501381
[TBL] [Abstract][Full Text] [Related]
12. Salecan protected against concanavalin A-induced acute liver injury by modulating T cell immune responses and NMR-based metabolic profiles.
Sun Q; Xu X; Yang X; Weng D; Wang J; Zhang J
Toxicol Appl Pharmacol; 2017 Feb; 317():63-72. PubMed ID: 28109817
[TBL] [Abstract][Full Text] [Related]
13. Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.
Lian F; Wang Y; Xiao Y; Wu X; Xu H; Liang L; Yang X
Mol Med Rep; 2015 Oct; 12(4):5821-7. PubMed ID: 26238153
[TBL] [Abstract][Full Text] [Related]
14. Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression.
Tu CT; Han B; Yao QY; Zhang YA; Liu HC; Zhang SC
Int Immunopharmacol; 2012 Jan; 12(1):151-7. PubMed ID: 22138522
[TBL] [Abstract][Full Text] [Related]
15. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis.
Kremer M; Hines IN; Milton RJ; Wheeler MD
Hepatology; 2006 Jul; 44(1):216-27. PubMed ID: 16799967
[TBL] [Abstract][Full Text] [Related]
16. The protective action of scutellarin against immunological liver injury induced by concanavalin A and its effect on pro-inflammatory cytokines in mice.
Tan ZH; Yu LH; Wei HL; Liu GT
J Pharm Pharmacol; 2007 Jan; 59(1):115-21. PubMed ID: 17227628
[TBL] [Abstract][Full Text] [Related]
17. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation.
Ren J; Meng S; Yan B; Yu J; Liu J
Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849
[TBL] [Abstract][Full Text] [Related]
18. Silibinin protects mice from T cell-dependent liver injury.
Schümann J; Prockl J; Kiemer AK; Vollmar AM; Bang R; Tiegs G
J Hepatol; 2003 Sep; 39(3):333-40. PubMed ID: 12927918
[TBL] [Abstract][Full Text] [Related]
19. Ectopic B7-H4-Ig expression attenuates concanavalin A-induced hepatic injury.
Xu JF; Xiao H; Hu GY; Zheng SH; Liu W; Yuan CL; Yang H; Lü J; Zheng F; Wang CY; Gong FL
Clin Immunol; 2010 Jul; 136(1):30-41. PubMed ID: 20346734
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-11 reduces T-cell-dependent experimental liver injury in mice.
Bozza M; Bliss JL; Maylor R; Erickson J; Donnelly L; Bouchard P; Dorner AJ; Trepicchio WL
Hepatology; 1999 Dec; 30(6):1441-7. PubMed ID: 10573523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
